Valvular heart disease, infected valves and prosthetic heart valves

Area of Science:

• Cardiology
• Vascular Medicine
• Thrombosis Research

Background:

• Systemic embolism is a serious complication of various heart valve conditions.
• Valvular heart disease, prosthetic valves, and endocarditis are primary sources of embolic events.
• Understanding the incidence and complications is crucial for effective management.

Purpose of the Study:

• To review the major causes of systemic embolism from valvular heart disease, prosthetic valves, and endocarditis.
• To outline current recommendations for antithrombotic therapy.
• To emphasize the importance of adhering to guidelines for risk reduction.

Main Methods:

• Review of literature on systemic embolism from valvular heart disease, prosthetic valves, and endocarditis.
• Analysis of incidence and complication data.
• Synthesis of recommendations from the Second American College of Chest Physicians Conference on Antithrombotic Therapy.

Main Results:

• Identified valvular heart disease (mitral, aortic, prolapse), prosthetic valves (mechanical, tissue), and infected valves (endocarditis) as key sources of systemic embolism.
• Provided recommendations for anticoagulant and antithrombotic therapy based on established guidelines.
• Highlighted the significant risk reduction achievable through adherence to these therapeutic strategies.

Conclusions:

• Adherence to updated antithrombotic therapy guidelines is essential for minimizing systemic embolism risk.
• Effective management of valvular heart conditions, prosthetic valves, and endocarditis requires tailored antithrombotic strategies.
• Implementing these recommendations can substantially improve patient outcomes by preventing embolic events.